DiJoseph J F, Borella L E, Mir G N
Department of Immunopharmacology, Wyeth-Ayerst Research Inc., Princeton, New Jersey.
Gastroenterology. 1989 Mar;96(3):730-5.
Removing the buffering capacity of aluminum-containing antacids by acidification greatly increased their cytoprotective activity over the parent antacid. Commercially available antacids were acidified with 6 N HCl. Peak mucosal protective activity occurred at pH 2.5, and declined at lower pH. At pH 2.5, the antacid suspensions became solubilized and no acid-neutralizing capacity remained. This solution was named activated aluminum complex. Based on aluminum ion content, each aluminum-containing antacid suspension tested demonstrated a comparable increase in potency on acidification against ethanol-induced lesions. HCl (pH 2.5) was inactive against ethanol-induced lesions. At cytoprotective doses, activated aluminum complex did not cause gastric lesions when orally administered by itself, demonstrating that it is not acting as a local mucosal irritant. The data suggest that solubilization of aluminum-containing antacids in acidic medium enhances their mucosal protective activity, probably by releasing an activated species of aluminum ion reported to be a hexaaquoaluminum cation.
通过酸化去除含铝抗酸剂的缓冲能力,大大提高了它们相对于母体抗酸剂的细胞保护活性。市售抗酸剂用6N盐酸酸化。黏膜保护活性峰值出现在pH 2.5,在更低pH值时下降。在pH 2.5时,抗酸剂悬浮液溶解,不再具有酸中和能力。该溶液被命名为活性铝络合物。基于铝离子含量,所测试的每种含铝抗酸剂悬浮液在酸化后对乙醇诱导损伤的效力都有相当程度的提高。盐酸(pH 2.5)对乙醇诱导的损伤无活性。在细胞保护剂量下,活性铝络合物单独口服时不会引起胃部损伤,表明它不是局部黏膜刺激物。数据表明,含铝抗酸剂在酸性介质中的溶解增强了它们的黏膜保护活性,可能是通过释放一种据报道为六水合铝阳离子的活性铝离子物种。